COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,757 Articles (22,943 medRxiv, 8,814 bioRxiv)

Most recent first Previous |  Page 9: Articles 81-90  | Next

Single-dose Efficacy of a Next-Generation Mpox Vaccine Harnessing an Immunomodulatory Peptide
Koehler, H. S., Karunathilake, A., Miah, R., Lawson, C., Burleson, J., Oruganti, S. R., Hauser, M. J., Domi, A., Adragna, B., Olsen, B., Bai, S., Kumaria, P., Gunn, B. M., Newman, M.
10.64898/2026.07.31.742137 — Posted: 2026-08-03
A panel of biologically contained orthoebolaviruses for the screening of broad-spectrum antivirals
Verlinden, J., Stroobants, J., Nonay, J. S., Willems, C., Govaerts, K., Van Holm, B., Chiu, W., Schepers, J., Francken, T., Lemmens, V., Vermeire, K., Vanmechelen, B.
10.64898/2026.07.28.741243 — Posted: 2026-07-31
Neuroanatomical subtypes of Long COVID reveal distinct cognitive profiles alongside longitudinal brain changes
Romero-Molina, A. O., McCord, B., Fernandez-Ruiz, J., Owen, A. M., Hernandez-Castillo, C.
10.64898/2026.07.30.741878 — Posted: 2026-07-31
SRARec: A program for detecting recombination in sequencing reads and its application to uncover recombination patterns in SARS-CoV-2 and HIV-1
Gonzalez Vazquez, L. D., Iglesias Rivas, P., Arenas, M., Martin, D. P.
10.64898/2026.07.30.741747 — Posted: 2026-07-30
Beyond the blood: Tissue-resident immunity shapes SARS-CoV-2 vaccine antibody responses
Schröter, J., van Dorp, C. H., Davis-Porada, J., Teijaro, J. R., Farber, D. L., Yates, A. J.
10.64898/2026.07.23.740375 — Posted: 2026-07-24
SARS-CoV-2 nucleocapsid protein engages with viral RNA and ERGIC lipids to drive viral core assembly
Swarnakar, S., Mishra, J., Rat, V., Merida, P., Bunel, L., Avinens, D., Feuillard, J., Lyonnais, S., Martinez, E., Swain, J., Dufourt, J., Blaise, M., Favard, C., Basu, J. K., Muriaux, D.
10.64898/2026.07.23.740351 — Posted: 2026-07-23
Epigenetic Regulation of Stable SARS-CoV-2 RBD-sfGFP Expression in Primary Human Splenic Fibroblasts
Maan, K. S., Baloch, Z. A., Bhullar, S. S., Vashishat, I., Assogba, B. D.
10.64898/2026.07.22.739919 — Posted: 2026-07-23
Antibody evasion and receptor binding of SARS-CoV-2 variants PQ.16.1.1 and RK.1
He, P., Song, Y., Guo, C., Yu, L., Yu, Y., Jian, F., Shao, F., Cao, Y.
10.64898/2026.07.21.739818 — Posted: 2026-07-23
IFNγ at the crossroads of systemic protection and brain vulnerability to coronavirus infection
Sabater, A., Arevalo, A. P., Perbolianachis, P., Sanchis, P., Pascual, G., Porfido, J. L., Seniuk, R., Portela, M., Valacco, M. P., Cotignola, J., Vazquez, E., Labanca, E., Carballeda, J. M., Moreno, P., Moratorio, G., Crispo, M., Gueron, G., Toro, A.
10.64898/2026.07.17.739144 — Posted: 2026-07-23
Localized Rigidification and Allosteric Modulation Mechanisms of SARS-CoV-2 Spike Neutralization by Class 3 and Class 4 Antibodies at Atomic Resolution: An Integrated Computational Study of Binding, Dynamics, and Allostery
Alshahrani, M., Gatlin, W., Ludwick, M., Turano, L., Foley, B., Verkhivker, G.
10.64898/2026.07.12.738055 — Posted: 2026-07-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).